Diana Ernst, RPh

Editorial Director

Diana Ernst, RPh, is the Editorial Director for MPR, part of the Haymarket Medical Network. Since 2003, Diana has worked to provide healthcare professionals with up-to-date drug information through MPR's print and digital offerings. She is a graduate of the Ernest Mario School of Pharmacy, Rutgers University.

All articles by Diana Ernst, RPh

FDA HQ

General Medicine

Second Booster Dose Authorized to Up Protection Against COVID-19 for Certain People

By

Diana Ernst, RPh

April 1, 2022

The Emergency Use Authorization was based on safety and immunogenicity data provided to the Agency.

AAN: Painful Diabetic Neuropathy Treatment Guidelines Updated

By

Diana Ernst, RPh

January 5, 2022

Several pharmacotherapies have been shown to reduce pain in patients with painful diabetic neuropathy.

Doctor and patient wearing masks.

General Medicine

CDC Issues Alert on Omicron Variant, Provides HCP Recommendations

By

Diana Ernst, RPh

December 7, 2021

The CDC is recommending that health care providers take a travel history for all suspected and confirmed cases of COVID-19.

1-in-3 men have some form of cardiovascular disease, according to the American Heart Association. An estimated 2.8 million men experience stroke each year and hypertension is common in younger men. Routine check-ups are important to monitor heart health.

General Endocrinology

Study Examines Prevalence of BP-Elevating Med Use in Patients With Hypertension

By

Diana Ernst, RPh

November 29, 2021

The researchers examined data from the National Health and Nutrition Examination Survey.

elderly man with pill and water

Fracture Risk Assessed Among Users of SGLT-2 Inhibitors vs Other Antidiabetic Agents

By

Diana Ernst, RPh

November 4, 2021

The study authors conducted a nationwide cohort study that included 137,667 Medicare beneficiaries.

General Medicine

CDC: Booster Recommendations Expanded to All Authorized COVID-19 Vaccines

By

Diana Ernst, RPh

October 29, 2021

The CDC recommendations also allow for the use of a heterologous (or “mix and match”) booster dose.

General Medicine

FDA Authorizes Moderna, Janssen COVID-19 Booster Shots, Allows for Mix and Match

By

Diana Ernst, RPh

October 27, 2021

The decision comes following the results of two FDA advisory committee meetings.

influenza virus particles

General Medicine

ACIP: Updated Vaccine Guidance for the 2021-2022 Influenza Season

By

Diana Ernst, RPh

September 15, 2021

Routine annual vaccination is recommended for all patients 6 months of age and older who have no contraindications.

FDA to Review Cabozantinib for Thyroid Cancer

By

Diana Ernst, RPh

August 6, 2021

The sNDA is supported by data from the phase 3 COSMIC-311 study.

Faricimab Gets Priority Review for Wet AMD, Diabetic Macular Edema

By

Diana Ernst, RPh

August 4, 2021

The BLA submission is based on positive results across four phase 3 studies in wet AMD and DME.

Next post in Diabetes

FDA Clears FreeStyle Libre 2 App to Monitor Glucose Levels